Clinical Trial Update: BXCL501 After Stress to Increase Recovery Success [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BXCL501 for acute stress-related conditions is currently recruiting at the University of North Carolina, Chapel Hill. Indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder
• Stress Disorder
• Stress Reaction

Drugs mentioned

• BXCL501 (dexmedetomidine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Acute Stress Reaction, Acute Stress Disorder | Phase 2 | Status: RECRUITING